SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SANA

Sana Biotechnology, Inc.
NASDAQHealth Care

Latest close: 2.27 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 8, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record36415 flagged findings
Reported transactions (Form 4)80since Jan 6, 2025 · and 13 other holdings
Corporate events (8-K)22since Mar 2, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

biotechnology company

Source: Wikidata (CC0 1.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-10share offering or dilution eventfreshOpen filing ↗
    “…to our stockholders, restrict our operations, or require us to relinquish rights to our technologies or product candidates. Until…”
    +1 more passage from the same document
    • “…common stock and otherwise meet the requirements to be classified in equity, the Company recorded the consideration received…”
  • 2026-08-10export control restrictionsfreshOpen filing ↗
    “…be taken with respect to trade relations between the United States and China or other countries, what interactions, including…”
  • 2026-05-11share offering or dilution eventrecentOpen filing ↗
    “…common stock and otherwise meet the requirements to be classified in equity, the Company recorded the consideration received…”
    +3 more passages from the same document
    • “…stock and otherwise meet the requirements to be classified in equity, the Company recorded the consideration received from the…”
    • “…by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1 (File No. 333-252061), filed with the SEC on…”
    • “…to our stockholders, restrict our operations, or require us to relinquish rights to our technologies or product candidates. Until…”
  • 2026-05-11export control restrictionsrecentOpen filing ↗
    “…be taken with respect to trade relations between the United States and China or other countries, what interactions, including…”
  • 2026-04-13capital return (buybacks/dividends)recentOpen filing ↗
    “…where the securities of such series may be surrendered for registration of transfer or exchange and where notices and demands to…”
  • 2026-03-03share offering or dilution eventrecentOpen filing ↗
    “…NOTE This registration statement contains: • a base prospectus covering the offering, issuance and sale by us of our common…”
    +1 more passage from the same document
    • “…dated March 3, 2026, or the sales agreement, with TD Securities (USA) LLC, or TD Cowen. The base prospectus immediately follows…”
  • 2026-03-03capital return (buybacks/dividends)recentOpen filing ↗
    “…where the securities of such series may be surrendered for registration of transfer or exchange and where notices and demands to…”
  • 2026-03-03share offering or dilution eventrecentOpen filing ↗
    “…common stock and otherwise meet the requirements to be classified in equity, the Company recorded the consideration received…”
    +1 more passage from the same document
    • “…stock and otherwise meet the requirements to be classified in equity, the Company recorded the consideration received from the…”

1 older entry not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 364)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 6, 26Form 4 ↗Insider transaction
  • Sep 8, 268-K ↗Current report · Communication to the market
  • Aug 27, 26Form 4 ↗Insider transaction
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Robert Nelsen · 15.4% · event on Jun 30, 26 · amendment
  • Aug 10, 2610-Q ↗Quarterly report
  • Aug 10, 268-K ↗Current report · Results
  • Insider transaction · 9 Form 4 filingsshow all 9hide
  • Jun 5, 268-K ↗Current report · Shareholder vote results
  • May 21, 26SCHEDULE 13G ↗Passive stake · RA Capital Management, L.P. · 6.3% · event on May 14, 26
  • May 15, 268-K ↗Current report · Other events
  • May 11, 2610-Q ↗Quarterly report
  • May 11, 268-K ↗Current report · Results
  • Apr 24, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 24, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 24, 268-K ↗Current report · A senior executive left or was appointed
  • Apr 13, 26424B5 ↗Securities offering
  • Apr 13, 268-K ↗Current report · Other events

364 filings on record, the oldest from Dec 8, 20.

Listing the 25 most recent filings of the 364 on record.

8-Ks, explained

Stress2Structure9Governance11
  • Governance4 senior executive changes2025 – 2026show all 4hide
    • Apr 24, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 17, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 5, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Aug 29, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 7, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2024show all 3hide
    • Oct 8, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 12, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Apr 18, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 8, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Oct 10, 23StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Aug 21, 23StructureA material agreement was terminated8-K 1.02 ↗
  • Apr 28, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 10, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Nov 29, 22StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗
  • Structure3 material agreements entered2021 – 2022show all 3hide
    • Jun 1, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jan 11, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Oct 19, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 3, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 14, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

1 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Robert Nelsen15.4%Jun 30, 26SCHEDULE 13G/A ↗15 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • RA Capital Management, L.P.6.3%May 14, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.1%Dec 31, 25SCHEDULE 13G ↗1 earlier filing
  • The Vanguard Group4.8%Dec 31, 24SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jan 8, 25Sell$611KFMR LLC↗
  • Jan 8, 25Sell$163KFMR LLC↗
  • Jan 8, 25Sell$1.1MFMR LLC↗
  • Jan 8, 25Sell$7KFMR LLC↗
Stock compensation, tax and giftsshow the 36 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 5, 26Compensationamount n/aHans Edgar Bishop↗
  • Aug 27, 26Tax$169KDHAVALKUMAR DHIRAJLAL PATELEVP, Chief Scientific Officer↗
  • Aug 26, 26Compensationamount n/aDHAVALKUMAR DHIRAJLAL PATELEVP, Chief Scientific Officer↗
  • Jul 6, 26Compensationamount n/aHans Edgar Bishop↗
  • Apr 6, 26Compensationamount n/aHans Edgar Bishop↗
  • Mar 9, 26Tax$10KSusan D. WyrickSee Remarks↗
  • Mar 9, 26Tax$3KSusan D. WyrickSee Remarks↗
  • Mar 9, 26Tax$36KSteve HarrPresident & CEO↗
  • Mar 9, 26Tax$40KSteve HarrPresident & CEO↗
  • Mar 7, 26Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Mar 7, 26Compensationamount n/aSteve HarrPresident & CEO↗
  • Mar 6, 26Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Mar 6, 26Compensationamount n/aSteve HarrPresident & CEO↗
  • Mar 3, 26Tax$2KSusan D. WyrickSee Remarks↗
  • Mar 2, 26Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Jan 5, 26Compensationamount n/aHans Edgar Bishop↗
  • Jan 5, 26Tax$10KSusan D. WyrickSee Remarks↗
  • Jan 2, 26Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Dec 15, 25Tax$5KSusan D. WyrickSee Remarks↗
  • Dec 13, 25Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Dec 4, 25Tax$11KSusan D. WyrickSee Remarks↗
  • Dec 3, 25Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Oct 6, 25Compensationamount n/aHans Edgar Bishop↗
  • Jul 7, 25Compensationamount n/aHans Edgar Bishop↗
  • Jun 4, 25Tax$6KSusan D. WyrickSee Remarks↗
  • Jun 3, 25Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Apr 7, 25Compensationamount n/aHans Edgar Bishop↗
  • Mar 10, 25Tax$33KSteve HarrPresident & CEO↗
  • Mar 10, 25Tax$7KBernard J CassidyEVP & General Counsel↗
  • Mar 10, 25Tax$2KSusan D. WyrickSee Remarks↗
  • Mar 7, 25Compensationamount n/aSteve HarrPresident & CEO↗
  • Mar 7, 25Compensationamount n/aBernard J CassidyEVP & General Counsel↗
  • Mar 7, 25Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Mar 3, 25Tax$1KSusan D. WyrickSee Remarks↗
  • Mar 2, 25Compensationamount n/aSusan D. WyrickSee Remarks↗
  • Jan 6, 25Compensationamount n/aHans Edgar Bishop↗

The full record holds 82 transactions and goes back to Feb 3, 21.

Its sector and its market

Sana Biotechnology, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Sana Biotechnology, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Sana Biotechnology, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
364 documents on file, from Dec 8, 2020 to Oct 6, 2026.
Company description
Wikidata, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.